Exelixis, Storm to collaborate on cancer treatments
Exelixis and Storm Therapeutics have entered into an exclusive collaboration and license agreement to discover and develop new drug leads to treat cancer. Read More
Jackson Laboratory acquires Charles River Laboratories Japan
Biomedical research company the Jackson Laboratory has acquired Charles River Laboratories Japan's Research Models and Services business as a wholly owned subsidiary. Read More
Dialogue with regulators will help bring cell and gene therapies to market
CARLSBAD, CA - Open engagement and frequent communication with regulators is needed throughout the development process for cell and gene therapies to help bring them to market, according to an October 13 session at the Cell & Gene Meeting on the Mesa. Read More
Catching up with the Alliance for Regenerative Medicine at Cell & Gene Meeting on the Mesa
CARLSBAD, CA - What's going on at this week's Cell & Gene Meeting on the Mesa? ScienceBoard.net spoke with Stephen Majors, director of public affairs at the Alliance for Regenerative Medicine, who shared what's being discussed at this year's meeting. Read More
What's next for cellular immunotherapies?
CARLSBAD, CA - What's the next step in the development of cellular immunotherapies, particularly for liquid and solid tumors? At this week's Cell & Gene Meeting on the Mesa, Dr. Kanya Rajangam, PhD, of Nkarta Therapeutics explained the latest approaches. Read More
Immusoft, Takeda ink metabolic disorder cell therapy deal
Immusoft has signed a research and licensing deal with Takeda Pharmaceutical to develop cell therapies for rare inherited metabolic disorders that have manifestations in the central nervous system. Read More
MilliporeSigma doubles viral vector production with new facility
MilliporeSigma has opened a second contract development manufacturing facility in California to focus on viral vector technologies for cell and gene therapy. Read More
AGTC CEO to present at Cell & Gene Meeting on the Mesa
Biotechnology firm Applied Genetic Technologies (AGTC) President and CEO Sue Washer will present at the Cell & Gene Meeting on the Mesa in Carlsbad, CA, on October 13 at 11:15 a.m. PT. Read More
Mission Bio debuts new capabilities for cell, gene therapy
Mission Bio has unveiled its Tapestri Cell & Gene Therapy Solutions, a new addition to its Tapesti platform that can provide analytical characterization of genotype with phenotype simultaneously. Read More
Tenaya Therapeutics CEO to present at Cell & Gene Meeting
Faraz Ali, CEO of biotechnology firm Tenaya Therapeutics, will present on October 13 at 3:15 p.m. PT as part of a panel discussion at the Cell & Gene Meeting on the Mesa in Carlsbad, CA. Read More
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter